Teva to Sell Assets Such as Women's Health Unit to Cut Debt - Bloomberg
Teva Poised to Face U.S. Charges in Drug Price-Fixing Probe - Bloomberg
Teva CEO Resigns; Dividend Cut Should Be Next - Bloomberg
Sell Teva Pharmaceutical due to increasing generic drugs competition: Credit Suisse
Teva, Allergan Ready To Pay $5B To Settle Lawsuits Related To Opioid Painkillers: Bloomberg
The Pharma Job From Hell: Low Salary to Fix Sinking Giant Teva - Bloomberg
Teva CEO Steps Down After Patent Losses, Bribery Settlement; Stock Dives | Stock News & Stock Market Analysis - IBD
Teva, Units Held Liable for Fueling N.Y. Opioid Crisis - Bloomberg
Teva halts output at U.S. drug plant after FDA flags concerns | Reuters
Teva Plunges as U.S. Sales Drop Amid Generic Price Erosion - Bloomberg
Zantac Cancer Case in US Settles for $500,000 (PRGO, TEVA) - Bloomberg
Teva CEO Resigns; Dividend Cut Should Be Next - Bloomberg
The Pharma Job From Hell: Low Salary to Fix Sinking Giant Teva - Bloomberg
Opioid Manufacturer Teva Pharmaceuticals Reaches $4B Global Settlement | Law.com
Teva Sees Adderall Supply Delays Continuing for 2-3 Months (1)
Teva's Credit Rating Cut to Junk by Fitch - Bloomberg
Teva to Sell Record $5 Billion of Sustainability-Linked Bonds - Bloomberg
Teva's Budding Blockbuster Drugs Lend Respite From Legal Concerns - Bloomberg
CVS, Teva, Allergan and Endo reach $878 million deal with Florida over the opioid crisis - STAT
The Pharma Job From Hell: Low Salary to Fix Sinking Giant Teva - Bloomberg
The Difficulties of Cloning a CEO - Bloomberg
Teva's Trouble Was Predicted. Path to Recovery Not as Clear - Bloomberg
US states accuse Teva and other drugmakers of colluding to inflate prices over 1,000%
Teva Is Facing Adderall Supply Disruptions as Demand for ADHD Drug Soars - Bloomberg
Teva Pharmaceutical Will Pay Over $4 Billion in Opioid Settlement - Bloomberg
